On 2016-07-28, Meridian Bioscience Inc. (NASDAQ:VIVO) updated dividend disbursement of $0.2 a share for record date 2016-08-08. The dividend release date is 2016-08-18 while ex-dividend date is 2016-08-04.
When stock market is bearish, dividend-paying firms overcome the storm meaningfully better than firms that do not give payout. While dividend-compensating securities drop in a wide-ranging bearish scenario, they don’t commonly writhe like the general street average. During the crisis in 2008, while the average of market declined for stocks of companies not compensating dividends was closely 45%, dividend-paying organizations only drop 38% on average. The gap was much wider in the 2002 recession, when such dividend-paying firms drop by 10%, paralleled to non-dividend-paying organizations, which drop an average of 30%. Investments in dividend-paying organizations gave a big cushion against big losses for shareholders.
Last year, Meridian Bioscience Inc. (NASDAQ:VIVO) paid a total of $0.2 per share in payout. This numeral was $0.2 a share in the equivalent period last year demonstrating deviation of 0%.
Analysts have forecasted target of $19.6 based on 5 calls. The affirmative and bearish forecasts are $23 and $15, correspondingly.
With the application of calculated rating, Meridian Bioscience Inc. (NASDAQ:VIVO) score came at 3.29. For period ending on 2016-09-30 quarterly earnings can be discovered around 2016-11-03. While for the period ending on 2016-09-30, the projected EPS is $0.2.
Companies’ performance is gauged by their ability to outdo street expectations. All members track whether firms “achieve their consensus”, in simple words, can firms succeed to exceed analysts’ consensus numbers. Knowing the implication of those projections can aid investors overcome the volatility during quarterly report.
While shareholder’s investment choice shouldn’t be bigoted too intensely on whether firms meet, beat or fail the Street’s predictions, it’s convenient keeping a track on how earnings figures execute against quarterly forecasts.
Meridian Bioscience Inc. (NASDAQ:VIVO) recorded EPS of $0.21 for the quarter ending on 2015-09-30. The analysts’ estimate was $0.21, demonstrating a miss of $0 as against posted EPS.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...